DSpace About DSpace Software 日本語

01 奈良県立医科大学 >
011 医学部 >
0112 紀要 >
01121 Journal of Nara Medical Association >
Vol.56 No.1 >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10564/121

Authors: Hosokawa, Yukinari
Kishino, Tatsuki
Ono, Takamasa
Oyama, Nobuo
Momose, Hitoshi
Keywords: prostate biopsy
prostate carcinoma
Issue Date: 28-Feb-2005
Publisher: 奈良医学会
Citation: Journal of Nara Medical Association Vol.56 No.1 p.31-36
Abstract: Objectives: Transrectal needle biopsy of the prostate is essential for the diagnosis of prostate carcinoma, but there is no unanimity of opinion on the antibiotic prophylaxis for that procedure. This study was designed to explore appropriate prophylactic antimicrobial regimens. Methods: Sixty patients undergoing prostate biopsy were assessed for any overt febrile infection. In the first 30 cases constituting Group 1, ceftibuten (CETB) was administered orally at 200 mg b.i.d. for 3 days, beginning on the day of biopsy, which was also the day of admission (2-3 hours before biopsy). As no serious adverse events were seen among those patients, CETB was administered at 200 mg b.i.d. orally for only one day, the day of admission, in the latter 30 cases (Group 2), and the clinical responses of the groups were compared. Results: None developed a fever post-biopsy in Group 1, while there were 2 patients (6.7%) who developed a fever at >38° C in Group 2. There was no statistically significant intergroup difference in incidence of fever. Conclusions: The prophylactic antibiotic regimens administered in Groups 1 and 2 were considered to be comparable in efficacy.
URI: http://hdl.handle.net/10564/121
ISSN: 13450069
Appears in Collections:Vol.56 No.1

Files in This Item:

File Description SizeFormat
KJ00004166115.pdf406.62 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback